Form 6-K Rubico Inc. For: Jun 23
http://archive.fast-edgar.com/20260623/AP2DT22CZ22EM2ZA222B2ME5KOHMZZ22Z282
Filed on: June 23, 2026
Form 424B2 BANK OF NOVA SCOTIA
http://archive.fast-edgar.com/20260623/ARZ2Q22CZW22AJP2222M2ZZ2TM8LK72SA282
Filed on: June 23, 2026
Form 424B2 CITIGROUP INC
http://archive.fast-edgar.com/20260623/AA22N222Z222G2ZZ2Z2P2W48MLSEWK22Z282
Filed on: June 23, 2026
Form D CRED RN-D Cayman Unit
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 424B2 GOLDMAN SACHS GROUP INC
Filed Pursuant to Rule 424(b)(2)
Registration Statement No. 333-284538
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion. Dated June 22, 2026.
... (continue reading...)More SEC Filings
View Older Stories-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: BUTITTA CYNTHIA M
-
Form 4 Guardant Health, Inc. For: Jun 22 Filed by: Tariq Musa
-
Form 11-K JANUS HENDERSON GROUP For: Dec 31
-
Form 4 Guardant Health, Inc. For: Jun 22 Filed by: POTTER MYRTLE S
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Garland J. Scott
-
Form 8-K ENANTA PHARMACEUTICALS For: Jun 23
-
Form 425 Evernorth Holdings Inc. Filed by: Evernorth Holdings Inc.
-
Form 4 Guardant Health, Inc. For: May 21 Filed by: MIGNONE ROBERTO
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Hrustanovic Gorjan
-
Form FWP BofA Finance LLC Filed by: BofA Finance LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form FWP BANK OF AMERICA CORP Filed by: BANK OF AMERICA CORP /DE/
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: CLARK IAN T
-
Form 424B2 BofA Finance LLC
-
Form 424B3 CNL Strategic Capital,
-
Form D Kalea Ventures Funds
-
Form 424B2 HSBC USA INC /MD/
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Larson Yi
-
Form 6-K/A VivoPower PLC For: Jun 23
-
Form 11-K Liberty Energy Inc. For: Dec 31
-
Form D/A CAZ Private Equity Owner
-
Form 11-K Ingersoll Rand Inc. For: Dec 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Ballal Rahul D.
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 425 Axalta Coating Systems Filed by: AKZO NOBEL NV
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Horning Sandra
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: CAPELLO JEFFREY D
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 Indivior Pharmaceuticals For: Jun 22 Filed by: Ciaffoni Joseph
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Foster-Cheek Kaye I
-
Form APP ORDR J.P. Morgan Investment
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K CNL Strategic Capital, For: Jun 23
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Raman Prakash
-
Form 424B2 BofA Finance LLC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form APP NTC J.P. Morgan Investment
-
Form DEF 14A 22nd Century Group, Inc. For: Jun 23
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: FOUSE JACQUALYN A
-
Form 424B2 CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Solidion Technology Inc.
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: RAPPAPORT ANDREW
-
Form 424B2 CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
